Medication-Related Osteonecrosis of the Jaw in a Patient With Prostate Cancer: A Case Presentation With a One-Month Follow-Up

Charbel F Kachouh, Adam M Aboukhalil, Rosine H Hajj Chehadeh, Robert S Daccache, Hiam Y Wehbe, Samar A Bou Jaoude · 2026

Read Medication-Related Osteonecrosis of the Jaw in a Patient With Prostate Cancer: A Case Presentation With a One-Month Follow-Up by Charbel F Kachouh, Adam M Aboukhalil, Rosine H Hajj Chehadeh, Robert S Daccache, Hiam Y Wehbe, Samar A Bou Jaoude (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13333122.txt.

Description

Charbel F Kachouh and colleagues report a 2026 case of jaw bone death linked to medicines in a man with prostate cancer. Medication-related osteonecrosis of the jaw most often follows bisphosphonate therapy and remains a hard problem for dentists. Its signs vary by stage, judged from clinical and imaging findings. The patient was an 81-year-old man with a skin fistula and pus drainage from the lower right jaw.

He was on chemotherapy and had received zoledronic acid by vein every six months for ten years. Jaw bone death from medicines can show many lesion types, demanding careful examination, accurate diagnosis, and fitting care. The one-month follow-up in the title frames the short-term course after presentation. Dentists gain a reminder to ask about long-term bone drugs when jaw sores, fistulas, or drainage appear in cancer patients.

Catalog record

CREATORCharbel F Kachouh, Adam M Aboukhalil, Rosine H Hajj Chehadeh, Robert S Daccache, Hiam Y Wehbe, Samar A Bou Jaoude
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13333122

Browse the full library · About the Tower of Babel